Understanding Non-invasive Vagus Nerve Stimulation Effects in PTSD

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2026

Primary Completion Date

January 1, 2031

Study Completion Date

December 31, 2032

Conditions
PTSD - Post Traumatic Stress Disorder
Interventions
DEVICE

transcutaneous auricular vagus nerve stimulation

FDA-cleared Digitimer DS7A Constant Current Stimulator (Digitimer Ltd., USA) will deliver electrical stimulation for 60 mins. Active stimulation will consist of direct electrical stimulation to the inner side of the left tragus (anode on the cymba concha, cathode on the surface of the tragus), thereby stimulating the ABVN. Stimulation parameters will consist of 500μs pulse width, 25Hz frequency, delivered at 200% of each participant's individual perceptual threshold (PT) in 60sec on/off trains.

DEVICE

sham transcutaneous auricular vagus nerve stimulation

FDA-cleared Digitimer DS7A Constant Current Stimulator (Digitimer Ltd., USA) will deliver electrical stimulation for 60 mins. Sham will be delivered to the ear lobe. Stimulation parameters will consist of 500μs pulse width, 25Hz frequency, delivered at 200% of each participant's individual perceptual threshold (PT) in 60sec on/off trains.

Trial Locations (1)

48201

Tolan Park Research Clinic, Wayne State University, Detroit

All Listed Sponsors
lead

Wayne State University

OTHER